Author

Monica A. Basuki

The University of Sydney

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1 Research Focus:GWAS / association mapping· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Ali AfrasiabiiD· 1 shared David Alexander BrowniD· 1 shared David Richmond BoothiD· 1 shared Fiona C. McKayiD· 1 shared Graeme J. Stewart· 1 shared Grant Peter ParnelliD· 1 shared Nicole FewingsiD· 1 shared Ramya Chandramohan· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Ali AfrasiabiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic evidence that the latency III stage of Epstein-Barr Virus infection is a therapeutic target for Multiple Sclerosis

Ali Afrasiabi, Grant Peter Parnell, Nicole Fewings, Stephen D. Schibeci, Monica A. Basuki, Ramya Chandramohan, David Alexander Brown, Sanjay Swaminathan, Fiona C. McKay, Graeme J. Stewart, David Richmond Booth

The paper identifies EBV latency III stage as a therapeutic target for MS by linking MS risk SNPs to EBV transcription factors and miRNAs.

bioRxiv · Aug 13, 2018 · PreprintGenomics